Raaj Medisafe India (BOM:524502) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:524502 Raaj Medisafe India Ltd BOM:524502
65 GF Score
Price ₹72.50
GF Value ₹77.81
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Raaj Medisafe India Research & Development?

Raaj Medisafe India BOM:524502 65 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:524502 with a GF Score™ of 65/100 and a GF Value™ of ₹77.81 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Raaj Medisafe India's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Raaj Medisafe India  (BOM:524502) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Raaj Medisafe India Research & Development Related Terms

Raaj Medisafe India Research & Development Historical Data

* Premium members only.

The historical data trend for Raaj Medisafe India's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raaj Medisafe India Research & Development Chart

Raaj Medisafe India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Raaj Medisafe India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:524502
65GF Score
Raaj Medisafe India Ltd BOM:524502
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raaj Medisafe India Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Raaj Medisafe India (BOM:524502) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Raaj Medisafe India and its competitors.
Is Raaj Medisafe India's Research & Development too high?
Raaj Medisafe India's current Research & Development is ₹0.0 Mil. Overall, Raaj Medisafe India has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raaj Medisafe India's Research & Development compare to SW and PKG?
Raaj Medisafe India's Research & Development of ₹0.0 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Packaging & Containers company?
A good Research & Development depends on the Packaging & Containers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Raaj Medisafe India and its competitors. Raaj Medisafe India's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raaj Medisafe India stock overvalued right now?
Based on GuruFocus' analysis, Raaj Medisafe India (BOM:524502) is currently considered Fairly Valued. The stock's GF Value™ is ₹77.81, compared to a current price of ₹72.50 — trading 6.8% below its estimated fair value. The current Research & Development is ₹0.0 Mil. Raaj Medisafe India's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Raaj Medisafe India (BOM:524502), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raaj Medisafe India (BOM:524502) Overvalued in 2026?

Based on GuruFocus' analysis, Raaj Medisafe India stock appears to be undervalued. The current stock price of ₹72.50 is trading 6.8% below its estimated GF Value™ of ₹77.81. GuruFocus considers Raaj Medisafe India to be Fairly Valued.

Key valuation signals for BOM:524502:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹77.81 vs. price of ₹72.50 (6.8% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the BOM:524502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raaj Medisafe India Business Description

Address Maksi Road, 75/2 and 3, Industrial Area, Ujjain, MP, IND, 456010
Raaj Medisafe India Ltd is an India-based company engaged in manufacturing and selling plastic bottles, caps, plugs, aluminum caps, plastic liners, and related products. The firm operates in two segments: Plastic and HHygiene. The Company earns revenue mainly from the sale of packaging items.
65GF Score

Get the complete analysis for BOM:524502

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹72.50
Price
₹77.81
GF Value